Brent Furse
Chief Executive Officer at Vero Biotech LLC
Brent Furse active positions
Companies | Position | Start | End |
---|---|---|---|
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Director/Board Member | 2016-05-31 | - |
Chief Executive Officer | 2016-05-31 | - | |
President | 2016-05-31 | - | |
Vero Biotech, Inc. | Director/Board Member | 2016-05-31 | - |
Chief Executive Officer | 2016-05-31 | - | |
President | 2016-05-31 | - |
Career history of Brent Furse
Former positions of Brent Furse
Companies | Position | Start | End |
---|---|---|---|
THE MEDICINES COMPANY | Corporate Officer/Principal | 2000-05-31 | 2013-12-31 |
ANTHERA PHARMACEUTICALS, INC. | Director/Board Member | 2016-04-26 | - |
Independent Dir/Board Member | 2016-04-26 | - | |
Cardiorentis AG
Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland. | President | 2016-01-09 | - |
Training of Brent Furse
Mercer University | Masters Business Admin |
Kennesaw State University | Undergraduate Degree |
Statistics
International
United States | 7 |
Switzerland | 2 |
Operational
President | 3 |
Director/Board Member | 3 |
Undergraduate Degree | 2 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ANTHERA PHARMACEUTICALS, INC. | Health Technology |
Private companies | 4 |
---|---|
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
Cardiorentis AG
Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland. | Health Technology |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Health Technology |
Vero Biotech, Inc. |
- Stock Market
- Insiders
- Brent Furse
- Experience